Serious Shortage Protocol - Estraderm MX® 50mcg and 75 mcg patches

  • Home
  • News
  • Serious Shortage Protocol - Estraderm MX® 50mcg and 75 mcg patches
Add to CPD Start a discussion

Due to ongoing shortages, the Serious Shortage Protocols (SSPs) have been issued for Estraderm MX® 50 microgram and 75 microgram patches (SSPs 037 and 038).

The SSPs will enable community pharmacists across the UK to supply patients with Evorel® 50 microgram patches or Evorel® 75 microgram patches respectively. The SSPs are now available to view on the NHS Business Service Authority (BSA)’s dedicated SSP web page, along with supporting guidance.

The SSPs came into effect on 15 November 2022 and are currently due to expire on 13 January 2023. Should this change, the SSPs will be updated accordingly and published on the BSA web page.

If there are any questions regarding the SSPs, please contact the NHS Prescription Service:

To access the latest information about SSPs (including supporting guidance), please visit this page.

Expiry date: Dec 9th, 2022